Clinical Trial: COPAXONE® (glatiramer acetate)
| Description | |
|---|---|
| A randomized, double-blind, placebo-controlled, multicenter study of the effects of glatiramer acetate on the nerve fiber thickness and visual function in people who have experienced one episode of acute optic neuritis. | |
| Institution/Location | Contact Information |
| Multicenter California Colorado Florida Georgia Illinois Kansas Maryland Michigan Minnesota Missouri Montana North Carolina New Jersey New York Oklahoma Pennsylvania Texas Utah Virginia Washington Wisconsin | Visit http://www.tevaclinicaltrials.com/Acute-Optic-Neuritis/default.aspx Visit website |
Treatment mode of action: To affect nervous system function.
Institution(s): Multicenter, United States.
Type of MS: Pre-MS - people who have experienced first episode of optic neuritis.
Number of Subjects: 200
Funding: Teva Pharmaceutical Industries